Olema Pharmaceuticals's total assets for Q3 2025 were $352.45M, a decrease of -7.74% from the previous quarter. OLMA total liabilities were $44.97M for the fiscal quarter, a 22.30% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.